<DOC>
	<DOCNO>NCT00441688</DOCNO>
	<brief_summary>This study cross sectional observational study evaluate prevalence HLA-B*5701 major French ethnotypes . Any HIV-1 infected subject eligible study include antiretroviral therapy ( ART ) na√É-ve experienced subject irrespective abacavir use , well subject previously test HLA-B*5701 . Subjects approach standard clinic visit , subject consent prior study specific procedure . Subjects ask provide tissue sample ( cheek cell blood sample ) use assess HLA-B*5701 status central local methodology .</brief_summary>
	<brief_title>Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion criterion : HIV1 infect patient , ART naive experience age 18 year . Patients must either affiliated beneficiary social security category . Patient willing able understand provide write informed consent prior participation study . Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>HLAgenetics polymorphism</keyword>
	<keyword>Human Immunodeficiency virus</keyword>
</DOC>